- Home
- NCL vs BNGO Comparison
NCL vs BNGO Comparison
Compare NCL & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCL
- BNGO
- Stock Information
- Founded
- NCL 2013
- BNGO 2003
- Country
- NCL United States
- BNGO United States
- Employees
- NCL N/A
- BNGO N/A
- Industry
- NCL
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- NCL
- BNGO Industrials
- Exchange
- NCL Nasdaq
- BNGO Nasdaq
- Market Cap
- NCL 21.7M
- BNGO 24.3M
- IPO Year
- NCL 2023
- BNGO 2018
- Fundamental
- Price
- NCL $0.15
- BNGO $3.04
- Analyst Decision
- NCL
- BNGO Buy
- Analyst Count
- NCL 0
- BNGO 5
- Target Price
- NCL N/A
- BNGO $7.33
- AVG Volume (30 Days)
- NCL 1.3M
- BNGO 108.6K
- Earning Date
- NCL 08-26-2025
- BNGO 08-14-2025
- Dividend Yield
- NCL N/A
- BNGO N/A
- EPS Growth
- NCL N/A
- BNGO N/A
- EPS
- NCL N/A
- BNGO N/A
- Revenue
- NCL $14,192,050.00
- BNGO $27,426,000.00
- Revenue This Year
- NCL N/A
- BNGO N/A
- Revenue Next Year
- NCL N/A
- BNGO $15.54
- P/E Ratio
- NCL N/A
- BNGO N/A
- Revenue Growth
- NCL N/A
- BNGO N/A
- 52 Week Low
- NCL $0.14
- BNGO $2.68
- 52 Week High
- NCL $1.52
- BNGO $37.09
- Technical
- Relative Strength Index (RSI)
- NCL 33.89
- BNGO 42.36
- Support Level
- NCL $0.15
- BNGO $2.92
- Resistance Level
- NCL $0.17
- BNGO $3.33
- Average True Range (ATR)
- NCL 0.01
- BNGO 0.16
- MACD
- NCL 0.00
- BNGO 0.02
- Stochastic Oscillator
- NCL 8.33
- BNGO 33.33
About NCL Northann Corp.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.